The chronic treatment animals were implanted with osmotic minipumps (OMP; 42-day pumps; Alzet, Cupertino, CA) that were connected to unilateral cannulae (28 gauge; Alzet, Cupertino, CA) targeting one lateral ventricle. One group received chronic FN-439 infusion (n=7,1.5 μg/hr in 0.15μl/hr), whereas the other received chronic aCSF (n=7; 0.15μl/hr) during the dependence induction period and post-vapor self-administration sessions.